Citations 1
The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease
Patil, Seema , Bhat, Shubha , Limdi, Jimmy K. , Cross, Raymond K. , Cross, Raymond , Farraye, Francis A.
Inflammatory Bowel Diseases | March 30, 2022 | Volume: 28 | Issue: 12 | Pages: 1915-1923
Lay Summary Biosimilar medications have the potential to significantly reduce the cost of treatment in patients with inflammatory bowel disease. Observational studies have shown similar efficacy and safety of biosimilars to biologic reference products. Shared decision-making is crucial to the successful implementation of these agents.